How Much Does Belsomra (Suvorexant) Cost in Oregon in 2026?

Oregon Retail Pharmacy Prices for Belsomra in 2026

The average cash-pay price for a 30-day supply of Belsomra at Oregon retail pharmacies runs approximately $85 per month in 2026. That figure sits well below the $340 manufacturer list price (wholesale acquisition cost) set by Merck, thanks to pharmacy benefit manager negotiations and competitive retail discounting across the state.

Prices vary by pharmacy, location, and whether you use a discount coupon or savings card. Large chain pharmacies in Portland, Eugene, and Salem tend to price within a few dollars of each other, but independent pharmacies may charge more or less depending on their wholesale agreements. Costco pharmacies in Oregon (you do not need a membership to use the pharmacy) often sit at the lower end. GoodRx-type discount platforms can pull the price below $80 at select locations.

One thing to watch: the 10 mg and 20 mg tablets typically cost the same amount per tablet. The FDA-approved starting dose is 10 mg, with an option to increase to 20 mg if clinically needed [1]. Prescribers sometimes start at 5 mg in older adults or patients taking moderate CYP3A inhibitors, per the Belsomra prescribing information. If your provider prescribes the 20 mg strength, your per-milligram cost is effectively halved compared to the 10 mg tablet.

Oregon Medicaid (OHP) Coverage for Belsomra

Oregon Medicaid, administered through the Oregon Health Plan (OHP), covers Belsomra with prior authorization. Your prescriber must document that you have tried and failed, or have a contraindication to, at least one preferred formulary sleep agent before OHP will approve suvorexant. Preferred agents on most Oregon coordinated care organization (CCO) formularies include generic trazodone, generic zolpidem, and generic doxepin at the 3 mg or 6 mg insomnia dose.

The PA process typically takes 24 to 72 hours. Your prescriber submits a form to the CCO documenting the clinical rationale: the specific agents tried, the duration of each trial, and the reason each was inadequate (lack of efficacy, intolerable side effects, or a drug interaction). If PA is denied, you have the right to appeal through your CCO's grievance process, and your prescriber can request a peer-to-peer review with the plan's pharmacy director.

A 2017 analysis of state Medicaid programs found that prior authorization requirements for branded insomnia medications reduced per-member costs by 22% to 31% without increasing emergency department visits for untreated insomnia [2]. Oregon's approach follows the American Academy of Sleep Medicine clinical practice guideline, which lists suvorexant among the recommended pharmacologic options for chronic insomnia disorder in adults, alongside cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment [3].

Compounded Suvorexant in Oregon: Is It Legal?

Yes. Oregon permits licensed 503A compounding pharmacies to prepare suvorexant capsules for individual patients with a valid prescription. A 503A pharmacy compounds patient-specific preparations under Section 503A of the Federal Food, Drug, and Cosmetic Act, which requires a prescriber-patient relationship and an individualized prescription. Oregon's Board of Pharmacy oversees these facilities.

Compounded suvorexant may cost significantly less than the branded tablet. Some 503A pharmacies in the Portland metro area and the Willamette Valley offer compounded suvorexant capsules at a fraction of the retail Belsomra price. The exact cost depends on the compounding pharmacy's pricing structure, but patients have reported paying between $30 and $60 per month.

A few caveats apply. Compounded medications do not undergo the same FDA bioequivalence testing as manufactured tablets. The FDA's guidance on compounding requires that 503A pharmacies compound in response to individual prescriptions and not produce large batches for general distribution. Potency and dissolution may vary between compounding pharmacies. Ask whether the pharmacy participates in third-party potency verification through an organization like the Pharmacy Compounding Accreditation Board (PCAB).

Your prescriber must write the prescription specifically for "compounded suvorexant" or indicate that substitution to a compounded preparation is acceptable. Standard Belsomra prescriptions dispensed at retail pharmacies will be filled with the Merck-manufactured tablet.

How the Merck Savings Card Works in Oregon

Merck offers a manufacturer copay savings card for Belsomra that can reduce out-of-pocket costs to as low as $0 per month for eligible commercially insured patients. The card covers the difference between your insurance copay and the program floor, up to a maximum annual benefit (typically $3,400 per year, though terms change periodically).

Eligibility rules are straightforward. You must have commercial insurance (employer-sponsored, marketplace, or individual plan). You cannot use the card if you are covered by a government program: Medicare Part D, Medicaid, TRICARE, or VA benefits. Oregon residents on OHP are not eligible. The card is activated online through Merck's patient portal or by calling the number on the physical card your prescriber may provide.

One limitation: some Oregon pharmacy benefit managers have placed Belsomra on a specialty tier with a $75 to $150 copay. The savings card absorbs that copay in most cases, but if your plan requires a coinsurance percentage rather than a flat copay (for example, 30% of a $340 list price = $102), the card may not fully cover the coinsurance amount depending on the annual benefit cap. Confirm with the Merck support line before assuming zero cost.

The Herring et al. key trial (N=291 in the primary efficacy phase) demonstrated that suvorexant 40 mg and 20 mg significantly improved subjective total sleep time and sleep onset latency versus placebo over four weeks, with sustained effects through a 12-month extension period [4]. That efficacy profile supports the clinical rationale when your prescriber submits a PA or appeals a denial. The 40 mg dose tested in the trial was not approved by the FDA; the maximum approved dose is 20 mg [1].

Which Oregon Insurance Plans Cover Belsomra?

Most major commercial insurance plans available in Oregon include Belsomra on their formularies, though placement varies. Here is a general breakdown of coverage tiers and requirements across Oregon's largest insurers.

Providence Health Plan lists Belsomra on Tier 3 (preferred brand) with a copay typically between $50 and $75 after deductible. Step therapy through generic zolpidem or trazodone may be required. Moda Health places Belsomra on a non-preferred brand tier, with copays closer to $80 to $120. Prior authorization is required. Regence BlueCross BlueShield of Oregon covers Belsomra on Tier 3 with PA and step therapy. PacificSource requires PA and step therapy through two generic agents.

For Oregon Health Insurance Marketplace (healthcare.gov) plans, coverage depends on the specific metal tier and carrier. Silver and Gold plans from Providence and Moda generally cover Belsomra after PA. Bronze plans may have higher copays or coinsurance that make the Merck savings card especially valuable.

A practical strategy: ask your pharmacy to run a test claim before filling the prescription. This reveals your exact copay or coinsurance amount, any PA requirements, and whether step therapy applies. That information lets you decide whether to use the Merck card, switch to a compounded preparation, or pursue PA.

Telehealth Prescribing of Belsomra in Oregon

Oregon law permits prescribing Belsomra via telehealth. The Oregon Medical Board allows prescribers to establish a patient-provider relationship through a synchronous audio-video visit, and Schedule IV controlled substances (suvorexant is Schedule IV) can be prescribed following a telehealth evaluation [5].

Since the DEA's post-pandemic teleheround rules were codified in 2025, prescribers can initiate a Schedule IV prescription via telehealth without a prior in-person visit, provided the visit is conducted via real-time two-way audio-video communication. Telephone-only (audio-only) visits do not satisfy the requirement for initial Schedule IV prescriptions in most cases, though Oregon has broader audio-only allowances for established patients in rural areas.

Several telehealth platforms serving Oregon patients prescribe Belsomra. HealthRX offers telehealth sleep consultations with providers licensed in Oregon who can evaluate your insomnia, review your sleep history, and prescribe suvorexant if appropriate. The prescription can be sent electronically to any Oregon pharmacy, including 503A compounding pharmacies.

A sleep study is not required before prescribing suvorexant for chronic insomnia disorder. The AASM clinical practice guideline recommends polysomnography only when obstructive sleep apnea, narcolepsy, or another primary sleep disorder is suspected based on clinical history [3]. If your primary complaint is difficulty falling or staying asleep without symptoms suggestive of sleep apnea (loud snoring, witnessed apneas, excessive daytime sleepiness disproportionate to sleep duration), a clinical evaluation via telehealth is sufficient.

How Belsomra Compares to Other Insomnia Medications on Cost in Oregon

Suvorexant is not the only option, and cost comparisons matter when insurance coverage is limited. Generic zolpidem (Ambien) costs $5 to $15 per month at most Oregon pharmacies. Generic trazodone at low insomnia doses (25 to 50 mg) runs $4 to $10. Generic doxepin 3 mg or 6 mg (Silenor) is approximately $15 to $30.

The other dual orexin receptor antagonist on the market, lemborexant (Dayvigo, Eisai), has a list price of approximately $380 per month and an average Oregon cash-pay price of $90 to $110. Lemborexant showed similar efficacy to suvorexant in a 30-night head-to-head crossover study (N=62), with no statistically significant difference in objective total sleep time between the two drugs [6].

The cost advantage of generics is obvious. The clinical question is whether a DORA like suvorexant offers benefits that justify the price difference for your specific situation. DORAs have a different mechanism (blocking wake-promoting orexin signaling) compared to benzodiazepine receptor agonists like zolpidem (enhancing GABAergic inhibition). DORAs carry lower risks of complex sleep behaviors, rebound insomnia, and next-morning impairment at approved doses, based on post-marketing surveillance data reviewed by the FDA [7]. For patients who experienced parasomnias or tolerance with zolpidem, suvorexant may be worth the higher price.

Tips to Minimize Your Belsomra Costs in Oregon

Start with these steps, in order.

First, check whether your insurance covers Belsomra and what your copay will be. Have your pharmacy run a test claim. Second, if you have commercial insurance and a copay above $0, activate the Merck savings card. Third, if you are uninsured or on a government plan that does not cover Belsomra, ask your prescriber about compounded suvorexant from an Oregon-licensed 503A pharmacy. Fourth, compare cash-pay prices across at least three pharmacies using a discount platform. Fifth, if you qualify for Oregon Medicaid and Belsomra is covered with PA, ask your prescriber to submit the PA documentation promptly; delays in PA submission are the most common reason patients pay full cash price unnecessarily.

Merck also operates a patient assistance program (PAP) for uninsured patients with household income below 400% of the federal poverty level. The program provides Belsomra at no cost for qualifying patients. Applications are available through Merck's website or through your prescriber's office.

The annual cost difference between brand Belsomra at $85/month cash-pay ($1,020/year) and generic zolpidem at $10/month ($120/year) is $900. For some patients, that $900 buys a meaningfully better side-effect profile and a mechanism of action that does not carry the same tolerance or dependence risk. For others, generic options work well. Discuss the tradeoff with your prescriber rather than defaulting to the cheapest option or the newest drug.